Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-01-13

FDA Approved: OLANZAPINE AND FLUOXETINE — Supplemental Application (Par Health USA, LLC)

View source ↗

Summary

FDA approved a supplemental application for the generic combination of olanzapine and fluoxetine, manufactured by Par Health USA, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Olanzapine and fluoxetine (olanzapine; fluoxetine)

Snippet

SUPPL AP for OLANZAPINE AND FLUOXETINE (OLANZAPINE AND FUOXETINE)